U.S. pharma large copyright scrapped two experimental weight loss products final yr—a as soon as-everyday pill, lotiglipron, as a consequence of elevated liver enzymes and a two times-each day capsule, danuglipron, resulting from robust Negative effects—but CEO Albert Bourla has ment